
companies in three key areas
science leader
and funds





Portfolio
Paragon successfully launched multiple companies and maintains a consistent flow of businesses in development.
News
- Harmony Biosciences Announces Jeffery M. Dayno, M.D. Appointed President & Chief Executive Officer April 24, 2023
- Emalex Biosciences Announces First Patient Dosed in Phase 3 Trial of Ecopipam for Tourette Syndrome March 1, 2023
- Harmony Biosciences Reports Fourth Quarter and Full Year 2022 Financial Results and Business Updates February 21, 2023